Lee, K., Kim, B. J., Kim, M., Han, H. S., Kim, J. W., Park, Y. I., & Park, S. R. (2017). A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine. Cancer Res Treat.
Citação norma ChicagoLee, Keun-Wook, Bum Jun Kim, Mi-Jung Kim, Hye Sook Han, Jin Won Kim, Young Iee Park, and Sook Ryun Park. "A Multicenter Randomized Phase II Study of Docetaxel Vs. Docetaxel Plus Cisplatin Vs. Docetaxel Plus S-1 As Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed After Cisplatin Plus Either S-1 or Capecitabine." Cancer Res Treat 2017.
Citação norma MLALee, Keun-Wook, et al. "A Multicenter Randomized Phase II Study of Docetaxel Vs. Docetaxel Plus Cisplatin Vs. Docetaxel Plus S-1 As Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed After Cisplatin Plus Either S-1 or Capecitabine." Cancer Res Treat 2017.